News | July 04, 2007

Medipattern, HealthCareIQ Team Up to Support Reimbursement Process for B-CAD

July 5, 2007 - Medipattern Corp., developer of computer-aided diagnosis (CAD) solutions for breast ultrasound imaging, announced a strategic alliance with HealthcareIQ LLC, reaching an agreement where Medipattern’s clients will have access to payer-specific benefit plan rules, coding guidelines and medical necessity protocols.

To date, the alliance has benefited Medipattern’s clients through both claims submission support and the successful receipt of reimbursements for the reporting of findings used to evaluate and manage patient care and provide diagnostic indicators that substantiate evidenced-based medicine, all obtained through use of B-CAD. Nationally recognized healthcare insurance companies are paying for the supervision of the B-CAD evaluation and management procedure for reporting and review by radiologists.

“B-CAD is a procedure performed on outpatients using breast ultrasound images and as such is reimbursable under the American Medical Associations (AMA) Common Procedure Terminology (CPT) code guidelines for evaluation and management procedures,” said Arthur Gelber, president and CEO of HealthcareIQ.

“B-CAD includes an automated workflow that naturally follows the radiologists’ process for correctly classifying lesions into corresponding American College of Radiology (ACR) Breast Imaging Reporting And Data System (BI-RADS) terminology, which forms the basis for evidence-based reporting and compliance with not only the ACR but payers’ guidelines for appropriate billing and reporting requirements. B-CAD’s ability to convert the details captured during the review of ultrasound breast images in a natural language report helps reduce the need for transcription as well as providing a comprehensive record for physicians to track patient progress as they manage the patients’ care. Breast care clinics need to be able to track subtle changes over the course of years to provide adequate patient care. B-CAD uses the ACR BI-RADS lexicon for evaluation of lesions and its structured reporting provides the necessary framework for evidence of tracking care over the long term,” stated Jeff Collins, CEO of The Medipattern Corporation.

For more information: www.medipattern.com

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Zebra Medical Vision Collaborating With Google Cloud on AI-Based Imaging Platform
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
PowerLook Tomo Detection Named 2017 New Hampshire High Technology Council Product of the Year
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
20/20 GeneSystems Launches AI-Based Lung Cancer Detection Technology in China
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...
Overlay Init